Postpartum Depression Market Synopsis

Postpartum Depression Market Size Was Valued at USD 8.68 Billion in 2023, and is Projected to Reach USD 92.30 Billion by 2032, Growing at a CAGR of 30.04% From 2024-2032.

PPD is a broad diagnostic category that describes a set of pathophysiologic processes affecting a woman after childbirth; these processes manifest as various somatic, emotional, and cognitive changes. These may include recurrent depressive symptoms such as sadness, anxiety, fatigue and disturbed sleep and appetite which may complicate a mother’s care for herself and her baby. PPD most commonly develops within the first year after birth but may occur at any time during the first postpartum year and may range from mild to severe. PPD should not be overlooked because its effects may significantly affect the mother and her child’s wellbeing and development, and stability of the family. The treatment required includes counseling, and supportive care, as well medication and therefore call for holistic approach and more awareness during postpartum period.

• PPD is a major mental health disorder which affects a substantial percentage of mothers and is manifested by profound emotional distress and fatigue that impairs a mother’s capacity to properly attend to herself and her newborn. The market for postpartum depression is one which has the potential to experience significant growth in the coming years, mainly due to increased understandings of the role that maternal mental health plays in the process of child rearing. It is for this reason that this market has got numerous treatment procedures such as drug treatment, therapy, and other treatment procedures to suit each woman experiencing PPD as discussed below. In addition, new pathways such as telehealth has ensured that woman can easily access the market hence enhancing the market growth.
• In recent years, some factors have boosted the growth in the postpartum depression market, as discussed below. It is a known fact that maternal health is given more attention today than it was perhaps, some decades ago; it follows therefore that more care givers have been trained to identify women suffering from PPD. Apart from it, campaigns that have been carried out to remove stigma relating to mental health has encouraged women to ask for assistance. These are including hormonal changes, lack of social support and prior episodes of mental disorders which contribute to the efficacy increase of PPD, which in turn leads to the need for treatment. In addition, COVID-19 has also emphasized the demand for postpartum mental health services which subsequently has increased the adoption rate of teletherapy, and digital health in market defining the future prospect of the market.
• As the market for postpartum depression emerges , it is important that stakeholders in the field including the manufacturers of drugs for PPD, mental health providers and policy makers come up with better ways of managing this condition, increase its availability and spread the word on its causes and effects. Further investigation into biological, psychological and social aspects of PPD will improve the kinds of treatment approaches and provide for more personalised treatments. Due to the constant increase in innovative features and focus on maternal mental health, postpartum depression market has bright future in the future years and the overall results for moms and their families will be better.

Postpartum Depression Market Trend Analysis

Emerging Treatment Options in the Postpartum Depression Market

• There will always be a demand for a range of promptly effective treatments for PPD, since the incidence of this affliction has risen sharply. Despite pharmacotherapy with SSRI being an effective treatment for PPD, there is a growing interest in understanding nonpharmacological intervention. Psychotherapy including CBTs and IPTs has emerged into practice as a possible complementary or even an individual measure of treatment as it supposess fundamental coping strategies with adequate emotional backup needed by moms to be. Another advantage of support groups is that women have been finding other women who have similar experiences; helping them fight loneliness while going through adversity. Newer methods like, exercise programs and nutritional advice or other supportive measures are now being accorded a positive beneficial role in influencing the mental state of the lady, thereby forming an important part of the treatment regime for PPD.
• Similarly, the use of digital health solutions has increased conveniently and the individualization of the postnatal care practice. Teletherapy is now a common form of therapy through which mothers get therapy from the comfort of their homes, issues that may limit some mothers from attending physical sessions include child care or geographical restrictions. In addition, there are smartphones created for mental health check purposes which allow users to track their conditions, gather helpful information, and contact doctors. These technologies not only help deliver early intervention approaches, but also involve the mother in managing her mental health. Thus, as these digital platforms exist and will continue to advance, it can be expected that they will foster links in gaps within postpartum care services, making available more effective treatments accessible, and decreasing the alarming societal prejudice on the admission of seeking remedy for mental health problems.

The Impact of Early Screening and Collaborative Efforts on Postpartum Depression Management

• Increased knowledge of PPD has caused a change in traditional treatment of maternal mental health through provision of screening and early treating of the condition.. The recent development of screening tools like EPDS and PHQ-9 is earlier used at prenatal and postnatal checkups. Screening for PPD has mothers rated routinely so that healthcare providers can easily ascertain which mothers are at risk and deserve intervention. This anticipatory action does not only target to prevent worsening of short-term effects of PPD to the mothers, but also look forward to improving the long-term benefits of families, such as better father-child relationships and less depression in kids. In addition, including such screenings into primary care makes women accept help for mental disorders without any embarrassment or prejudice.• The focus on maternal mental health is further magnified by partnership between the healthcare facilities, policy makers and non-governmental organizations.on of early screening and intervention strategies. Standardized screening tools, such as the Edinburgh Postnatal Depression Scale (EPDS) and the Patient Health Questionnaire-9 (PHQ-9), are increasingly incorporated into prenatal and postnatal visits. By routinely assessing mothers for symptoms of PPD, healthcare providers can identify those at risk more effectively and facilitate timely interventions. This proactive approach not only aims to mitigate the immediate impacts of PPD on mothers but also seeks to enhance long-term outcomes for families, including improved parent-child bonding and reduced emotional distress in children. Furthermore, integrating these screenings into routine care fosters a culture of openness regarding mental health, encouraging mothers to seek help without stigma.
• The emphasis on maternal mental health is further amplified by collaborative efforts among various stakeholders, including healthcare systems, policymakers, and non-profit organizations. These partnerships are indispensable in supporting popularization of educational campaigns focused on PPD and mental health of women during and after childbirth. Wellness fairs and meetings, awareness information and community education programmes in the clinics, hospitals, antenatal clinics, and other supportive structures to both healthcare and expectant mothers are being created to explore, recognise, and seek help from PPD clinic. Furthermore, these partnership seek to increase existing commodities including the development of more support groups and referrals to health care workers with expertise in postpartum depression. Thus, as general awareness progresses, the market for postpartum depression worldwide is likely to gather pace. They also pointed to improvements in the numbers of treatment plans available, the efforts to go for preventative treatments rather than waiting for issues to become severe, along with better maternal health and improved family relationships as drivers for growth in the segment.

Postpartum Depression Market Segment Analysis:

Postpartum Depression Market Segmented based on By Type, By Treatment and By End-Users.

By Type, Postpartum Blues segment is expected to dominate the market during the forecast period

• A phenomena known as the Baby blues can be observed in countless new moms in the days and even weeks following the birth of their child.. These include ‘’mood swings, increased tender feelings, and sad to irritable,’’ commonly manifests between the third and fourth postnatal days, and rarely lasts more than two weeks. It is a very uncomfortable process for many women; they begin to worry about their health state of mind. Swings in hormones, long hours of labor and sleep loss, stress of caring for the new born are some of the reasons for these emotional changes. Even though postpartum blues are mild and last for a short period, they may negatively alter the period of the primary bonding of the mother and the baby as well as hinder her ability to perform the necessary tasks of the day ahead, which if unresolved, predispose the mother to more severe mental health issues.•: Due to increased population awareness of postpartum mental health problems, there is a growing focus on care for women experiencing postpartum blues.aracterized by mood swings, heightened emotional sensitivity, and feelings of sadness or irritability, these symptoms typically peak around the third or fourth day post-delivery and usually resolve within a couple of weeks. The experience can be distressing for many women, leading to concerns about their mental health and well-being. The fluctuation of hormones, physical exhaustion from labor, and the overwhelming responsibility of caring for a newborn can all contribute to these emotional changes. While postpartum blues are generally temporary and do not require clinical intervention, they can interfere with a mother’s ability to bond with her baby and manage essential daily tasks, potentially setting the stage for more serious mental health issues if left unaddressed.
• As awareness of postpartum mental health issues continues to rise, there is a growing emphasis on providing support for mothers experiencing postpartum blues. This is because there is growing concern in offering community programs and educational interventions particularly to young mothers to support healthy postnatal mental health. Such programs are in many ways as support groups, counseling, informative materials meant to assist women in handling their emotions and roles. Moreover, primary care givers are encouraged to ask all postpartum women about their experiences of postpartum blues during their follow up clinic visits so as to get a timely help. This way, the helps mothers to feel less isolation, and gives them confidence to enjoy the mothership-hood, and form strong, healthy relationships with their babies.

By End-Users, Hospitals segment held the largest share in 2023

• Hospitals therefore form the entry port to addressing PMMH, having a direct interface with new mothers during a period of transition. Specialized maternity wards give the institutions a unique chance to identify postpartum complications since both maternal and neonatal care is provided in hospitals. Having mental health workers embedded in such contexts can contribute to improved care, and facilitate cooperation between obstetricians and pediatricians with mental health professionals. This coordinated care approach makes certain that after delivery the mother who may likely be suffering from postpartum depression, anxiety or other related disorders is attended to, which is paramount in identifying the right treatment methodology. Hospitals should ensure that woman get counseling, support groups other forms of assistance besides the food to enable them embrace their well being through boosts the body and the mind since the mind is part and parcel of the body.
• Moreover, regarding the program facilitation it is equally important to focus on specific training initiatives aimed at the hospital’s employees. It would take a long time and effort to educate all the healthcare providers to become aware of the finer details of postpartum mental health that make up a situation and reduce the feeling of embarrassment and other negative connotations that are attached to them. In the same way, by training the staff, inclusive of nurses, midwives, as well as physicians, on appropriate patient relations and understanding of such women’s plight, then new born infants can be born in an understanding environment and treated tenderly. Besides, it is always useful to find out that staff can update their knowledge about the new researches and recommendations in the field of maternal mental health. Creating awareness of the issues facing new moms in the hospital helps increase support towards new moms, and this is helpful in improving the experience and consequently the results of both mother and the child. This approach is not only helpful for concrete individual families, but also useful for constructing a different societal attitude towards the significance of maternal mental health.

Postpartum Depression Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• In the selected regions which include the United States and Canada in North America, the marketplace for PPD is boosted by tremendous healthcare development that recognizes the need to offer support to postpartum women. The various health risk factors that come with healthcare services also encompassing different professionals, such obstetricians, psychiatrists, and social workers provide women with the required means to attend to PPD. The treatment that is available is quite progressive, with available psychotherapeutic interventions ranging from Cognitive Behavioral therapy; they also have ample access to pharmacotherapy with antidepressants. Another implementation has also come up as very relevant in managing PPD is through integration of telehealth services so that the mother can easily get the services from her home especially after delivery since travelling is a challenge. More healthcare organizations, NGO’s and advocacy groups have embarked on raising awareness on PPD through awareness campaigns which has made providers as well as the population at large easily recognize symptoms of PPD thus enhancing early diagnosis and treatment.
• Furthermore, the role of the government has been very key in the market for postpartum depression treatment in both United States and Canada. The goals of enhancing maternal care standards have resulted in instructional funding of mental health needs and institutionalization of screening tests during prenatal and postnatal visits. Both the American College of Obstetricians and Gynecologists (ACOG) and Health Canada have recently raised awareness on better screening and diagnostic practices in postpartum depression and have encouraged integration of the concept with mother care. This has facilitated many healthcare providers to weigh women for PPD often and to provide them with a referral to a mental health provider when required. Therefore, the promotion of maternal mental health has changed from an approach centered on illness to an approach that encourages women to get better care for postpartum depression and actually get it. The sum total of all these developments is that the PPD market is increasing at a slow and steady pace in North America and is setting the standard for the global maternal mental health market.

Active Key Players in the Postpartum Depression Market

• Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Novartis AG (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• AstraZeneca (UK)
• Johnson & Johnson Private Limited (US)
• Bayer AG (Germany)
• Merck & Co., Inc. (US)
• Hoffmann-La Roche Ltd. (Switzerland)
• Eli Lilly and Company (US)
• Cipla Inc. (US)
• Aurobindo Pharma (India)
• Lupin (India)
• Accord Healthcare (US)
• Sun Pharmaceutical Industries Ltd. (India)
• Bausch Health Companies Inc. (Canada)
• Alvogen (US)
• Intas Pharmaceuticals Ltd. (India)
• SHIONOGI & Co., Ltd. (Japan
• Other Key Players

Key Industry Developments in the Postpartum Depression Market:

• In Aug, 2024 U.S. Food and Drug Administration Rejected MDMA Psychotherapy for PTSD (post-traumatic stress disorder).
• In July, 2024 discovery of TRPC5 gene's role in obesity and postnatal depression offers hope for new treatments.
• In July 2023, the U.S. Preventive Services Task Force (USPSTF) updated its guidelines to recommend universal screening for PPD during and after pregnancy, improving early detection and intervention.
• In January, 2024 the "Maternal Mental Health Matters" campaign, launched by the World Health Organization (WHO), aims to increase global awareness and support for PPD, emphasizing the importance of mental health during the postpartum period.
• In 2024, several new digital platforms and mobile apps, such as Perinatal Support, have been introduced, offering virtual therapy and AI-driven mental health support tailored specifically for postpartum women.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Postpartum Depression Market by Type
 4.1 Postpartum Depression Market Snapshot and Growth Engine
 4.2 Postpartum Depression Market Overview
 4.3 Postpartum Blues
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Postpartum Blues: Geographic Segmentation Analysis
 4.4 Postpartum Anxiety
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Postpartum Anxiety: Geographic Segmentation Analysis
 4.5 Postpartum Obsessive Compulsive Disorder
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Postpartum Obsessive Compulsive Disorder: Geographic Segmentation Analysis
 4.6 Postpartum Panic Disorder
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Postpartum Panic Disorder: Geographic Segmentation Analysis
 4.7 Postpartum Post-Traumatic Stress Disorder
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Postpartum Post-Traumatic Stress Disorder: Geographic Segmentation Analysis
 4.8 Postpartum Psychosis
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 Postpartum Psychosis: Geographic Segmentation Analysis

Chapter 5: Postpartum Depression Market by Treatment
 5.1 Postpartum Depression Market Snapshot and Growth Engine
 5.2 Postpartum Depression Market Overview
 5.3 Psychotherapy
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Psychotherapy: Geographic Segmentation Analysis
 5.4 Medication
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Medication: Geographic Segmentation Analysis
 5.5 Supplements
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Supplements: Geographic Segmentation Analysis

Chapter 6: Postpartum Depression Market by End-Users
 6.1 Postpartum Depression Market Snapshot and Growth Engine
 6.2 Postpartum Depression Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Geographic Segmentation Analysis
 6.4 Specialty Clinics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Specialty Clinics: Geographic Segmentation Analysis
 6.5 Homecare
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Homecare: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Postpartum Depression Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 PFIZER INC (US)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 GLAXOSMITHKLINE PLC (UK)
 7.4 NOVARTIS AG (SWITZERLAND)
 7.5 MYLAN N.V. (US)
 7.6 TEVA PHARMACEUTICAL INDUSTRIES LTD (ISRAEL)
 7.7 SANOFI (FRANCE)
 7.8 ASTRAZENECA (UK)
 7.9 JOHNSON & JOHNSON PRIVATE LIMITED (US)
 7.10 BAYER AG (GERMANY)
 7.11 MERCK & CO
 7.12 INC (US)
 7.13 HOFFMANN-LA ROCHE LTD (SWITZERLAND)
 7.14 ELI LILLY AND COMPANY (US)
 7.15 CIPLA INC (US)
 7.16 AUROBINDO PHARMA (INDIA)
 7.17 LUPIN (INDIA)
 7.18 ACCORD HEALTHCARE (US)
 7.19 SUN PHARMACEUTICAL INDUSTRIES LTD (INDIA)
 7.20 BAUSCH HEALTH COMPANIES INC (CANADA)
 7.21 ALVOGEN (US)
 7.22 INTAS PHARMACEUTICALS LTD (INDIA)
 7.23 SHIONOGI & CO
 7.24 LTD (JAPAN)
 7.25 OTHER ACTIVE PLAYERS

Chapter 8: Global Postpartum Depression Market By Region
 8.1 Overview
 8.2. North America Postpartum Depression Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
  8.2.4.1 Postpartum Blues
  8.2.4.2 Postpartum Anxiety
  8.2.4.3 Postpartum Obsessive Compulsive Disorder
  8.2.4.4 Postpartum Panic Disorder
  8.2.4.5 Postpartum Post-Traumatic Stress Disorder
  8.2.4.6 Postpartum Psychosis
  8.2.5 Historic and Forecasted Market Size By Treatment
  8.2.5.1 Psychotherapy
  8.2.5.2 Medication
  8.2.5.3 Supplements
  8.2.6 Historic and Forecasted Market Size By End-Users
  8.2.6.1 Hospitals
  8.2.6.2 Specialty Clinics
  8.2.6.3 Homecare
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Postpartum Depression Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
  8.3.4.1 Postpartum Blues
  8.3.4.2 Postpartum Anxiety
  8.3.4.3 Postpartum Obsessive Compulsive Disorder
  8.3.4.4 Postpartum Panic Disorder
  8.3.4.5 Postpartum Post-Traumatic Stress Disorder
  8.3.4.6 Postpartum Psychosis
  8.3.5 Historic and Forecasted Market Size By Treatment
  8.3.5.1 Psychotherapy
  8.3.5.2 Medication
  8.3.5.3 Supplements
  8.3.6 Historic and Forecasted Market Size By End-Users
  8.3.6.1 Hospitals
  8.3.6.2 Specialty Clinics
  8.3.6.3 Homecare
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Postpartum Depression Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
  8.4.4.1 Postpartum Blues
  8.4.4.2 Postpartum Anxiety
  8.4.4.3 Postpartum Obsessive Compulsive Disorder
  8.4.4.4 Postpartum Panic Disorder
  8.4.4.5 Postpartum Post-Traumatic Stress Disorder
  8.4.4.6 Postpartum Psychosis
  8.4.5 Historic and Forecasted Market Size By Treatment
  8.4.5.1 Psychotherapy
  8.4.5.2 Medication
  8.4.5.3 Supplements
  8.4.6 Historic and Forecasted Market Size By End-Users
  8.4.6.1 Hospitals
  8.4.6.2 Specialty Clinics
  8.4.6.3 Homecare
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Postpartum Depression Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
  8.5.4.1 Postpartum Blues
  8.5.4.2 Postpartum Anxiety
  8.5.4.3 Postpartum Obsessive Compulsive Disorder
  8.5.4.4 Postpartum Panic Disorder
  8.5.4.5 Postpartum Post-Traumatic Stress Disorder
  8.5.4.6 Postpartum Psychosis
  8.5.5 Historic and Forecasted Market Size By Treatment
  8.5.5.1 Psychotherapy
  8.5.5.2 Medication
  8.5.5.3 Supplements
  8.5.6 Historic and Forecasted Market Size By End-Users
  8.5.6.1 Hospitals
  8.5.6.2 Specialty Clinics
  8.5.6.3 Homecare
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Postpartum Depression Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
  8.6.4.1 Postpartum Blues
  8.6.4.2 Postpartum Anxiety
  8.6.4.3 Postpartum Obsessive Compulsive Disorder
  8.6.4.4 Postpartum Panic Disorder
  8.6.4.5 Postpartum Post-Traumatic Stress Disorder
  8.6.4.6 Postpartum Psychosis
  8.6.5 Historic and Forecasted Market Size By Treatment
  8.6.5.1 Psychotherapy
  8.6.5.2 Medication
  8.6.5.3 Supplements
  8.6.6 Historic and Forecasted Market Size By End-Users
  8.6.6.1 Hospitals
  8.6.6.2 Specialty Clinics
  8.6.6.3 Homecare
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Postpartum Depression Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
  8.7.4.1 Postpartum Blues
  8.7.4.2 Postpartum Anxiety
  8.7.4.3 Postpartum Obsessive Compulsive Disorder
  8.7.4.4 Postpartum Panic Disorder
  8.7.4.5 Postpartum Post-Traumatic Stress Disorder
  8.7.4.6 Postpartum Psychosis
  8.7.5 Historic and Forecasted Market Size By Treatment
  8.7.5.1 Psychotherapy
  8.7.5.2 Medication
  8.7.5.3 Supplements
  8.7.6 Historic and Forecasted Market Size By End-Users
  8.7.6.1 Hospitals
  8.7.6.2 Specialty Clinics
  8.7.6.3 Homecare
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research